| Element List | Explanation |
|---|---|
| Introduction | Miral Medical Clinics Company announces to its shareholders the results of the Extraordinary General Assembly Meeting (first meeting), which was held at (19:15) on Monday 12/20/1446 AH corresponding to 06/16/2025 AD at the company’s main headquarters in Riyadh, located in Al-Olaya District - Tahlia Street - via modern technology (remotely) - using Tadawulati services; after the legal quorum for the validity of the meeting of the assembly was completed |
| City and Location of the General Assembly's Meeting | The company's main headquarters in Riyadh, located in Al-Olaya District - Tahlia Street - via modern technology (remotely) - using Tadawulati services |
| Date of the General Assembly's Meeting | 2025-06-16 Corresponding to 1446-12-20 |
| Time of the General Assembly’s Meeting | 19:15 |
| Percentage of Attending Shareholders | %55.77 |
| Names of the Board of Directors' Members Present at the General Assembly's Meeting and Names of the Absentees | 1. Mr. Bandar Burjas Hamidi Al-Abdulkarim - Chairman of the Board of Directors 2. Mr. Yasser Ibrahim Abdulkarim Al-Obaida - Vice Chairman of the Board of Directors 3. Mr. Sami Abdullah Dakhil Allah Al-Saeed - Managing Director and Chief Executive Officer 4. Mr. Ali Abdullah Ali Al-Saqia - Board Member 5. Mr. Osama Saleh Ibrahim Al-Hadithi - Board Member |
| Names of the Chairmen of the Committees Present at the General Assembly's Meeting or Members of such Committees Attending on Their Behalf | 1. Mr. Osama Saleh Ibrahim Al-Hadith - Chairman of the Audit Committee |
| Voting Results on the Items of the General Assembly's Meeting Agenda's | 1. Approval of the company's auditors' report for the fiscal year ending December 31, 2024, after discussion. 2. The Board of Directors' report for the fiscal year ending December 31, 2024, was reviewed and discussed. 3. The company's financial statements for the fiscal year ending December 31, 2024, were reviewed and discussed. 4. Approval of the discharge of the members of the Board of Directors from liability for the fiscal year ending December 31, 2024. 5. Approval of the appointment of Mahm Professional Consulting Company as the company's auditor, from among the candidates nominated based on the Audit Committee's recommendation, to examine, review, and audit the company's interim financial statements for the first half ending June 30, 2025, and the annual financial statements ending December 31, 2025, for a fee of (190,000) one hundred and ninety thousand Saudi riyals. 6. Approval of the Board of Directors' authorization to distribute interim dividends to shareholders on a semi-annual or quarterly basis for the fiscal year ending December 31, 2025. 7. Approval of the Board of Directors' authorization of the Ordinary General Assembly's authority to authorize the Board of Directors under paragraph (1) of Article Twenty-Seven of the Companies Law, for a period of one year from the date of the General Assembly's approval or until the end of the term of the authorized Board of Directors, whichever is earlier, in accordance with the conditions stipulated in the Executive Regulations of the Companies Law for listed joint-stock companies. 8. Approval of the transfer of the statutory reserve balance of SAR 3,292,289, as shown in the annual financial statements ending December 31, 2024, to the retained earnings balance. 9. Approval of the transactions and contracts concluded between the Company's CEO and Managing Director (Dr. Sami Abdullah Al-Saeed), in which he has a direct interest, which are (commissions and bonuses). These transactions began in 2024, and the value of the transactions during 2024 is SAR 1,295,480.46. (Debit transactions) and the value of the amount paid during the year 2024 AD is (1,207,201) riyals (credit transactions) and the final balance for the year 2024 AD is (54,365) riyals, and these transactions are carried out in the course of normal business and in accordance with the prevailing commercial conditions and without any preferential conditions |